| Quarter | Score |
|---|---|
| 2022-Q1 | 49.5 |
| 2022-Q3 | 67.6 |
| 2022-Q4 | 49.4 |
| 2023-Q1 | 49.5 |
| 2023-Q2 | 41.5 |
| 2023-Q3 | 48.7 |
| 2023-Q4 | 65.8 |
| 2024-Q1 | 62.9 |
| 2024-Q2 | 67.9 |
| 2024-Q3 | 57.7 |
| 2024-Q4 | 57.6 |
| 2025-Q1 | 58.6 |
| 2025-Q2 | 61.9 |
| 2025-Q3 | 61.7 |
| 2025-Q4 | 98.9 |
| 2026-Q1 | 86.2 |
| 2026-Q2 | 86.4 |
High consensus with active accumulation at an attractive valuation
Within 7.3% of funds' estimated purchase price
2 of 18 tracked funds hold BLK. Avg conviction: 5.0%. Net adding. First tracked at $1009.92 (current +7.3% vs tracked).
ValueAct Capital has 9.9% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| ValueAct Capital | 9.9% | Add |
| Citadel Advisors | 0.1% | Add |